Speaker Profile
BS, Founder and CEO, NerView Surgical
Biography
Mann Parikh leads NerView Surgical, a medtech startup developing NerveSense, a contact-free imaging platform that makes peripheral nerves visible in real time during surgery. His work focuses on translating physics-based optics and AI into practical tools that reduce iatrogenic nerve injury across plastic, endocrine, and head and neck surgery.He has guided the company through multiple prototype generations, GLP-aligned preclinical study design, and early FDA engagement, securing competitive non-dilutive funding and building partnerships with leading centers such as Stanford, Mayo Clinic, and Harvard-affiliated hospitals. Beyond NerView, he contributes to surgical innovation and global health initiatives as a mentor, educator, and advisor to students and early-stage founders.
Talk
Real-Time Optical Mapping of Surgical Nerves
NerView Surgicals NerveSense platform uses polarized light, computer vision, and AI to give surgeons a real-time, contact-free map of peripheral nerves during open surgery. I will share preclinical and early clinical data, show how we align optical physics with surgical workflow, and outline our evidence and regulatory roadmap.
AI for Clinical Decision Support Systems Showcase:
NerView Surgical Inc.
NerView Surgical develops NerveSense, a handheld, contact-free imaging system that uses polarized light and AI to make peripheral nerves visible in real time during surgery. By standardizing intraoperative nerve visualization, we aim to reduce iatrogenic nerve injury and its clinical, economic, and medico-legal burden.
Session Abstract – PMWC 2026 Silicon Valley
"The PMWC 2026 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
